Our Science
Our goal is to alleviate patient suffering by developing novel Multi-specific Therapeutic Antibodies against cancers and other difficult-to-treat diseases. Ranging from small antigen-binding fragments to full length IgG-like molecules, Multi-specific antibodies come with novel activities that do not exist in the combination of the parental antibodies. We passionately believe that this can only be achieved by conducting rigorous, high-quality scientific research.